Showing results (1-10 of 1,593) with videos related to
Sort By:
Pageof 160
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 1, 1994
Recurrent acute pancreatitis induced by isoniazidK L Chan, H S Chan, S F Lui, et al.American Journal of Nephrology|January 1, 1992
Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in haemodialysis patientsS F Lui, K C Wong, P K Li, et al.Renal Failure|January 1, 1992
Acute renal failure (ARF) caused by rhabdomyolysis due to diabetic hyperosmolar nonketotic coma: a case report and literature reviewC B Leung, P K Li, S F Lui, et al.Angiology|November 20, 1998
Treatment of Takayasu's aortitis with percutaneous transluminal angioplasty and wall stent--a case reportY M Wang, G Y Mak, K N Lai, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 1, 1992
Use of recombinant erythropoietin in thalassemic patients on dialysisK N Lai, K C Wong, P K Li, et al.Clinical and Experimental Immunology|August 1, 1991
Cytokine production by peripheral blood mononuclear cells in IgA nephropathyK N Lai, J C Leung, P K Li, et al.Clinical Nephrology|November 1, 1991
Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysisS F Lui, C B Law, S M Ting, et al.Nephron|January 1, 1991
Effect of subcutaneous and intraperitoneal administration of recombinant human erythropoietin on blood pressure and vasoactive hormones in patients on continuous ambulatory peritoneal dialysisK N Lai, S F Lui, J C Leung, et al.Clinical Nephrology|January 1, 1990
Pharmacokinetics and pharmacodynamics of subcutaneous and intraperitoneal administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysisS F Lui, W W Chung, C B Leung, et al.Pageof 160